Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Lapatinib | 0.01 | uM | 9 | 5000.00 | 2099.14 | 10865.00 | 11036.50 | 0.9845 | 0.9870 |
MCF 10A | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 2099.14 | 10800.00 | 11036.50 | 0.9786 | 0.9820 |
MCF 10A | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2099.14 | 10787.00 | 11036.50 | 0.9774 | 0.9810 |
MCF 10A | Erlotinib | 1 | uM | 9 | 5000.00 | 2099.14 | 3031.00 | 11036.50 | 0.2746 | 0.1658 |
MCF 10A | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 2099.14 | 11213.00 | 11036.50 | 1.0160 | 1.0133 |
MCF 10A | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 2099.14 | 7680.00 | 11036.50 | 0.6959 | 0.7190 |
MCF 10A | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2099.14 | 1506.00 | 11036.50 | 0.1365 | -0.1295 |
MCF 10A | 0 | uM | 9 | 5000.00 | 2099.14 | 11672.00 | 11036.50 | 1.0576 | 1.0473 | |
MCF 10A | 0 | uM | 9 | 5000.00 | 2099.14 | 10993.00 | 11036.50 | 0.9961 | 0.9967 | |
MCF 10A | Linsitinib | 1 | uM | 9 | 5000.00 | 2099.14 | 9097.00 | 11036.50 | 0.8243 | 0.8449 |
MCF 10A | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2099.14 | 7850.00 | 11036.50 | 0.7113 | 0.7347 |
MCF 10A | 0 | uM | 9 | 5000.00 | 2099.14 | 10965.00 | 11036.50 | 0.9935 | 0.9946 | |
MCF 10A | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 2099.14 | 6345.00 | 11036.50 | 0.5749 | 0.5872 |
MCF 10A | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 2099.14 | 10911.00 | 11036.50 | 0.9886 | 0.9905 |
MCF 10A | Erlotinib | 10 | uM | 9 | 5000.00 | 2099.14 | 2539.00 | 11036.50 | 0.2301 | 0.0827 |
MCF 10A | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2099.14 | 2725.00 | 11036.50 | 0.2469 | 0.1151 |
MCF 10A | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 2099.14 | 10800.00 | 11036.50 | 0.9786 | 0.9820 |
MCF 10A | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2099.14 | 10834.00 | 11036.50 | 0.9817 | 0.9846 |
MCF 10A | Linsitinib | 0.01 | uM | 9 | 5000.00 | 2099.14 | 11203.00 | 11036.50 | 1.0151 | 1.0125 |
MCF 10A | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 2099.14 | 11083.00 | 11036.50 | 1.0042 | 1.0035 |
MCF 10A | 17-AAG | 0.01 | uM | 9 | 5000.00 | 2099.14 | 11155.00 | 11036.50 | 1.0107 | 1.0089 |
MCF 10A | Linsitinib | 10 | uM | 9 | 5000.00 | 2099.14 | 7240.00 | 11036.50 | 0.6560 | 0.6771 |
MCF 10A | 0 | uM | 9 | 5000.00 | 2099.14 | 11153.00 | 11036.50 | 1.0106 | 1.0088 | |
MCF 10A | Lapatinib | 1 | uM | 9 | 5000.00 | 2099.14 | 9640.00 | 11036.50 | 0.8735 | 0.8901 |
MCF 10A | Lapatinib | 10 | uM | 9 | 5000.00 | 2099.14 | 2784.00 | 11036.50 | 0.2523 | 0.1252 |